Running title: Postprandial apoA-V in type 2 diabetes

[1]  P. Talmud,et al.  Evidence for a complex relationship between apoA-V and apoC-III in patients with severe hypertriglyceridemia Published, JLR Papers in Press, July 21, 2006. , 2006, Journal of Lipid Research.

[2]  G. Watts,et al.  Apolipoproteins C-III and A-V as Predictors of Very-Low-Density Lipoprotein Triglyceride and Apolipoprotein B-100 Kinetics , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[3]  L. Pennacchio,et al.  Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment. , 2005, The Journal of clinical investigation.

[4]  L. Pennacchio,et al.  Apolipoprotein A-V Deficiency Results in Marked Hypertriglyceridemia Attributable to Decreased Lipolysis of Triglyceride-Rich Lipoproteins and Removal of Their Remnants , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[5]  M. Taskinen,et al.  Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes , 2005, Diabetologia.

[6]  A. Boodhoo,et al.  The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins. , 2005, Clinical chemistry.

[7]  G. Livolti,et al.  Inherited Apolipoprotein A-V Deficiency in Severe Hypertriglyceridemia , 2005 .

[8]  K. V. van Dijk,et al.  ApoAV Reduces Plasma Triglycerides by Inhibiting Very Low Density Lipoprotein-Triglyceride (VLDL-TG) Production and Stimulating Lipoprotein Lipase-mediated VLDL-TG Hydrolysis* , 2004, Journal of Biological Chemistry.

[9]  Len A Pennacchio,et al.  Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5. , 2004, Biochemical and biophysical research communications.

[10]  M. Taskinen,et al.  Effects of nateglinide and glibenclamide on postprandial lipid and glucose metabolism in type 2 diabetes , 2002, Diabetes/metabolism research and reviews.

[11]  Jonathan C. Cohen,et al.  An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing , 2001, Science.

[12]  M. Taskinen,et al.  Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease. , 2000, Atherosclerosis.

[13]  M. Taskinen,et al.  Postprandial elevation of ApoB-48-containing triglyceride-rich particles and retinyl esters in normolipemic males who smoke. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[14]  S Senn,et al.  Analysis of serial measurements in medical research. , 1990, BMJ.

[15]  P. Kinnunen,et al.  An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma. , 1975, Clinica chimica acta; international journal of clinical chemistry.

[16]  K. V. van Dijk,et al.  Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism. , 2007, Atherosclerosis.